Dr Neil Mehta discusses the recent updates on policies for liver transplantation in patients with hepatocellular carcinoma (HCC).
Dr Neil Mehta discusses the recent updates on policies for liver transplantation in patients with hepatocellular carcinoma (HCC).
Dr Neil Mehta underwent medical training at the University of California, San Francisco (UCSF). He was an Intern then a Resident at the Hospital of the University of Pennsylvania before becoming a Fellow in Gastroenterology and Transplant Hepatology at UCSF. He is Associate Professor in Medicine at UCSF and has held this position since 2013. He is specifically interested in issues related to the diagnosis and management of patients with hepatocellular carcinoma (HCC) particularly with regards to outcomes in liver transplantation.
Fujifilm Wako
Moderated by the Oncology Brothers. Episode 1 of a 3-part video podcast series
An interactive patient case video series from breast cancer specialists
How will the latest data impact clinical practice?
An expert panel discussion hosted by eChinaHealth and COR2ED
How will the latest data impact clinical practice?